Marc Maegele1, Thomas Paffrath, Bertil Bouillon. 1. Klinik für Unfallchirurgie, Orthopädie und Sporttraumatologie, Kliniken der Stadt Köln gGmbH. Marc.Maegele@t-online.de
Abstract
BACKGROUND: Clinical observation and research findings show that acute traumatic coagulopathy (ATC) is a major factor that must be addressed in the care of severely injured patients. In this review article, we discuss the incidence and causes of ATC, the potential means of early risk stratification for it, and recommendations for its treatment. METHODS: We selectively reviewed the pertinent literature and retrospectively analyzed data from the Trauma Registry of the German Trauma Society (Traumaregister der Deutschen Gesellschaft für Unfallchirurgie, TR-DGU) relating to the incidence, causes, and outcome of ATC. We provide an overview of current treatment recommendations, supplemented by our own findings regarding the ratio of packed red blood cell concentrate (pRBC) to fresh-frozen plasma (FFP) transfusion and regarding coagulation-factor-based treatments for coagulopathy in the acute phase after trauma. RESULTS AND CONCLUSION: ATC, a condition associated with increased morbidity and mortality, is seen on admission in one out of four patients with major trauma. The main causes of ATC are tissue damage, hypoperfusion, hemodilution, hypothermia, acidosis, and inflammation. It may be possible to identify patients at risk for ATC early on through the use of rapidly calculable, predictive numerical scales (McLaughlinScore, TASH, and ABC), laboratory tests, and imaging studies (FAST and CT). Acute treatment is focused on the control of bleeding and support of the coagulation system according to the current guidelines. Patients at high risk may benefit from a balanced transfusion strategy. Innovative strategies currently under study include point-of-care-guided treatment and coagulation-factor-concentrate-based treatment.
BACKGROUND: Clinical observation and research findings show that acute traumatic coagulopathy (ATC) is a major factor that must be addressed in the care of severely injured patients. In this review article, we discuss the incidence and causes of ATC, the potential means of early risk stratification for it, and recommendations for its treatment. METHODS: We selectively reviewed the pertinent literature and retrospectively analyzed data from the Trauma Registry of the German Trauma Society (Traumaregister der Deutschen Gesellschaft für Unfallchirurgie, TR-DGU) relating to the incidence, causes, and outcome of ATC. We provide an overview of current treatment recommendations, supplemented by our own findings regarding the ratio of packed red blood cell concentrate (pRBC) to fresh-frozen plasma (FFP) transfusion and regarding coagulation-factor-based treatments for coagulopathy in the acute phase after trauma. RESULTS AND CONCLUSION: ATC, a condition associated with increased morbidity and mortality, is seen on admission in one out of four patients with major trauma. The main causes of ATC are tissue damage, hypoperfusion, hemodilution, hypothermia, acidosis, and inflammation. It may be possible to identify patients at risk for ATC early on through the use of rapidly calculable, predictive numerical scales (McLaughlinScore, TASH, and ABC), laboratory tests, and imaging studies (FAST and CT). Acute treatment is focused on the control of bleeding and support of the coagulation system according to the current guidelines. Patients at high risk may benefit from a balanced transfusion strategy. Innovative strategies currently under study include point-of-care-guided treatment and coagulation-factor-concentrate-based treatment.
Authors: Bernard Floccard; Lucia Rugeri; Alexandre Faure; Marc Saint Denis; Eileen Mary Boyle; Olivier Peguet; Albrice Levrat; Christian Guillaume; Guillaume Marcotte; Alexandre Vulliez; Etienne Hautin; Jean Stéphane David; Claude Négrier; Bernard Allaouchiche Journal: Injury Date: 2010-11-26 Impact factor: 2.586
Authors: L Rugeri; A Levrat; J S David; E Delecroix; B Floccard; A Gros; B Allaouchiche; C Negrier Journal: J Thromb Haemost Date: 2006-11-16 Impact factor: 5.824
Authors: Matthew A Borgman; Philip C Spinella; Jeremy G Perkins; Kurt W Grathwohl; Thomas Repine; Alec C Beekley; James Sebesta; Donald Jenkins; Charles E Wade; John B Holcomb Journal: J Trauma Date: 2007-10
Authors: Sarah E Niles; Daniel F McLaughlin; Jeremy G Perkins; Charles E Wade; Yuanzhang Li; Philip C Spinella; John B Holcomb Journal: J Trauma Date: 2008-06
Authors: Daniel F McLaughlin; Sarah E Niles; Jose Salinas; Jeremy G Perkins; E Darrin Cox; Charles E Wade; John B Holcomb Journal: J Trauma Date: 2008-02
Authors: Mitchell Jay Cohen; Matt Kutcher; Britt Redick; Mary Nelson; Mariah Call; M Margaret Knudson; Martin A Schreiber; Eileen M Bulger; Peter Muskat; Louis H Alarcon; John G Myers; Mohammad H Rahbar; Karen J Brasel; Herb A Phelan; Deborah J del Junco; Erin E Fox; Charles E Wade; John B Holcomb; Bryan A Cotton; Nena Matijevic Journal: J Trauma Acute Care Surg Date: 2013-07 Impact factor: 3.313
Authors: A Wafaisade; H Wyen; M Mutschler; S Lendemans; B Bouillon; S Flohe; T Paffrath; M Maegele; T Tjardes; C Probst Journal: Unfallchirurg Date: 2015-12 Impact factor: 1.000
Authors: Timur Sellmann; Daniel Miersch; Peter Kienbaum; Sascha Flohé; Johannes Schneppendahl; Rolf Lefering Journal: Dtsch Arztebl Int Date: 2012-12-07 Impact factor: 5.594
Authors: M Burkhardt; U Nienaber; J Krause; A Pizanis; P Moersdorf; U Culemann; E Aghayev; T Paffrath; T Pohlemann; J H Holstein Journal: Unfallchirurg Date: 2015-11 Impact factor: 1.000
Authors: Rolf Rossaint; Bertil Bouillon; Vladimir Cerny; Timothy J Coats; Jacques Duranteau; Enrique Fernández-Mondéjar; Daniela Filipescu; Beverley J Hunt; Radko Komadina; Giuseppe Nardi; Edmund A M Neugebauer; Yves Ozier; Louis Riddez; Arthur Schultz; Jean-Louis Vincent; Donat R Spahn Journal: Crit Care Date: 2016-04-12 Impact factor: 9.097